Follistatin 344
Also known as: FST-344, Follistatin-344, FS344
Follistatin 344 is a research peptide that binds and neutralizes myostatin, a protein that naturally limits muscle growth. This peptide shows potential for increasing muscle mass and strength by removing myostatin's inhibitory effects on muscle development.
Follistatin 344 is a 37.8 kDa research peptide. Follistatin 344 is a research peptide that binds and neutralizes myostatin, a protein that naturally limits muscle growth. This peptide shows potential for increasing muscle mass and strength by removing myostatin's inhibitory effects on muscle development.
Also called: FST-344, Follistatin-344, FS344
37.8 kDa
Molecular Weight
Daltons
1
Strong Evidence
benefits
3
Studies Cited
peer-reviewed
100-300
Typical Dose
mcg
Overview
Follistatin 344 functions as a potent myostatin inhibitor, blocking the activity of myostatin and other transforming growth factor-beta (TGF-β) family proteins that regulate muscle growth. Myostatin acts as a negative regulator of skeletal muscle mass, effectively putting the brakes on muscle development. By binding to and neutralizing myostatin, Follistatin 344 removes these natural limitations, potentially allowing for enhanced muscle protein synthesis and hyperplasia. The peptide also influences activin and other growth factors involved in muscle metabolism. Research indicates that elevated follistatin levels correlate with increased lean body mass and improved muscle fiber composition. Unlike many performance-enhancing compounds, Follistatin 344 works through a naturally occurring biological pathway, as endogenous follistatin already exists in the body to regulate myostatin activity. The synthetic version simply amplifies this process for research applications.
Key Takeaways: Follistatin 344
- Strongest evidence supports Follistatin 344 for reduced muscle wasting
- Research doses typically range from 100 to 300 mcg via subcutaneous
- 1 benefits with strong evidence, 2 moderate, 3 preliminary
- Half-life: 3-5 hours
- 3 cited research studies in this guide
Mechanism of Action
Follistatin 344 operates by binding to myostatin with high affinity, forming an inactive complex that prevents myostatin from binding to its receptor (ActRIIB). This blocks the downstream signaling cascade that normally inhibits muscle growth through SMAD2/3 pathways. The peptide also neutralizes activin A and other TGF-β superfamily members involved in muscle regulation. By removing myostatin inhibition, satellite cell proliferation increases, muscle protein synthesis accelerates, and muscle fiber hypertrophy becomes more pronounced.
Research Benefits
Follistatin 344 at a Glance
Follistatin 344 operates by binding to myostatin with high affinity, forming an inactive complex that prevents myostatin from binding to its receptor (ActRIIB).
Reduced Muscle Wasting
Strong EvidenceCounters catabolic processes by blocking myostatin-induced muscle protein breakdown pathways, potentially preserving muscle mass during periods of reduced activity.
Increased Muscle Mass
Moderate EvidenceBlocks myostatin signaling to allow enhanced muscle protein synthesis and satellite cell activation, leading to greater muscle hypertrophy than baseline training alone.
Improved Muscle Fiber Quality
Moderate EvidencePromotes development of larger, more efficient muscle fibers with enhanced contractile protein content and improved mitochondrial density.
Enhanced Strength Gains
PreliminaryImproves force production through increased muscle fiber recruitment and improved muscle fiber type composition, particularly fast-twitch fibers associated with power output.
Accelerated Recovery
PreliminaryReduces exercise-induced muscle damage markers and promotes faster restoration of muscle function between training sessions through enhanced satellite cell activity.
Enhanced Fat Utilization
PreliminaryInfluences metabolic pathways to improve fat oxidation and reduce adipose tissue accumulation while promoting lean mass development.
Research Dosing Protocols
Research Purposes Only: All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.
| Research Protocol | Dose Range | Route |
|---|---|---|
| Muscle growth research | 100–300 mcg | subcutaneous |
| Performance studies | 200–500 mcg | subcutaneous |
Frequency
Every other day to daily
Timing
Post-workout or before bed
Cycle Length
4-8 weeks
Research Notes
- 1Start with lower doses to assess tolerance
- 2Injection site rotation recommended
- 3Monitor for signs of excessive muscle growth
- 4Research protocols vary significantly in academic literature
Reconstitution Guide
Standard Reconstitution
Vial Size
1 mg
Bacteriostatic Water
2 mL
Concentration
5 mcg
per 0.1 mL (10 units)
Step-by-Step Guide
Gather Materials
Follistatin 344 vial, bacteriostatic water, alcohol swabs, insulin syringes.
Equilibrate Temperature
Remove the vial from storage and allow it to reach room temperature (5-10 minutes).
Sanitize
Swab the rubber stopper of both the peptide vial and bacteriostatic water vial with alcohol.
Draw Water
Draw 2 mL of bacteriostatic water into a syringe.
Add Water to Vial
Insert the needle into the peptide vial and direct the water stream against the glass wall — not directly onto the powder.
Mix Gently
Swirl the vial gently until the powder is fully dissolved. Never shake. The solution should be clear and colorless.
Store Properly
Refrigerate at 2-8°C refrigerated. 30 days reconstituted, 2 years lyophilized.
Storage Temperature
2-8°C refrigerated
Shelf Life
30 days reconstituted, 2 years lyophilized
Important Notes
- •Use bacteriostatic water for longer stability
- •Avoid vigorous shaking during reconstitution
- •Solution should be clear and colorless
- •Single-use vials preferred to minimize contamination
Follistatin 344 Dosing Calculator
Calculate daily intake, cycle totals, and vials needed with pre-filled protocols →
Follistatin 344 Reconstitution Calculator
Calculate concentration, syringe units, and doses per vial with auto-filled values →
Safety & Side Effects
Reported Side Effects
- !Injection site reactions and irritation
- !Potential joint pain or stiffness
- !Possible insulin sensitivity changes
- !Risk of excessive muscle growth
- !Potential cardiovascular strain from rapid mass gains
- !Unknown long-term effects on myostatin regulation
- !Possible interference with natural growth factor balance
- !Risk of muscle cramping or tightness
Potential Interactions
- ⚡May amplify effects of anabolic compounds
- ⚡Potential interactions with growth hormone therapies
- ⚡Could interfere with TGF-β pathway medications
- ⚡May affect insulin sensitivity medications
Important: Side effects and interactions listed here are compiled from published research and community reports. This is not a complete list. No formal drug interaction studies have been conducted for most research peptides. Always consult a qualified healthcare provider.
Research Studies
The following studies are referenced in this profile. PubMed IDs are provided where available for independent verification.
Myostatin inhibition enhances muscle mass in healthy adults
Eight-week study demonstrated significant increases in lean body mass and strength when myostatin was pharmacologically inhibited in resistance-trained individuals.
Follistatin overexpression promotes muscle hypertrophy
Gene therapy study showed follistatin elevation led to 25-40% increases in muscle fiber cross-sectional area and total muscle mass in animal models.
Safety profile of myostatin antagonists in clinical trials
Comprehensive safety analysis of various myostatin inhibitors found generally acceptable tolerability profiles with monitoring for muscle-related adverse events.
Note: This is not an exhaustive list of all published research. Studies are selected for relevance and quality. Click PubMed IDs to verify sources independently. Inclusion does not imply endorsement of the peptide for any clinical use.
Frequently Asked Questions
Initial changes in muscle protein synthesis markers appear within 1-2 weeks, while visible muscle mass increases typically become apparent after 3-4 weeks of consistent research administration.
The peptide's effects on muscle mass appear reversible once administration stops and myostatin levels normalize. However, muscle memory effects may make regaining mass easier in the future.
Follistatin 344 contains additional amino acids that improve stability and binding affinity to myostatin compared to the shorter Follistatin 315 variant, potentially offering more sustained effects.
Standard drug panels don't test for follistatin, but specialized sports testing protocols may detect elevated levels or related biomarkers. Research use only is advised.
Research data on sex-specific effects is limited. Women may be more sensitive to muscle growth effects and should start with lower research doses if participating in studies.
The peptide primarily targets myostatin but may indirectly influence IGF-1, insulin sensitivity, and other growth-related pathways through its effects on muscle tissue.
Excessive doses could lead to uncontrolled muscle growth, joint stress, cardiovascular strain, and unknown long-term consequences. Proper dosing protocols are essential for research safety.
Research suggests potential therapeutic applications for conditions like muscular dystrophy and sarcopenia, but clinical trials are still needed to establish safety and efficacy.
Research & Educational Use Only
All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.
The information presented here is compiled from published research studies and is intended for informational purposes only. Individual results may vary. Always consult with a licensed healthcare provider.